Top Market Research Companies in Egypt (2026 Guide)

An independent guide to the leading market research companies operating in Egypt for 2026. This article profiles 5 firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Egypt-specific expertise, and what to look for when shortlisting a research partner for the largest market in MENA.

Why Egypt Matters for Market Research in 2026

Egypt is the largest market in MENA by population (109M+) and has the strongest local pharmaceutical manufacturing base in the region, with approximately 90% of medicines consumed produced domestically. The pharmaceutical market is valued at $5.8 billion and growing at 9.2% year-over-year.

The Egyptian Drug Authority (EDA), established in 2020, is modernising pharmaceutical regulation. Universal Health Insurance (Hayah Karima) is expanding coverage, driving new demand for evidence-based decision-making. For multinational pharmaceutical companies, Egypt offers scale, a growing addressable market, and an export gateway to Africa.

For market research buyers, Egypt presents specific challenges: diverse stakeholder landscapes across government and private channels, Arabic-language requirements, EDA-specific regulatory context, and the need for culturally grounded fieldwork across Cairo, Alexandria, and Upper Egypt. Choosing the right research partner is critical.

For additional context, see our pharmaceutical companies in Egypt guide, healthcare market research in Egypt hub, and the BioNixus strategic portfolio.

How to Evaluate a Market Research Partner for Egypt

When shortlisting market research companies for Egypt, consider these criteria beyond standard RFP evaluation:

1. BioNixus — Dual-Practice Specialist

HQ: USA (HQ) / UK / Egypt

BioNixus is headquartered in the USA with regional offices in the UK and Egypt, making it the only firm with this structure offering dual-practice coverage across healthcare/pharma and consumer sectors. With 127+ completed projects, 48 global clients, and a 15-year track record, BioNixus combines deep local fieldwork capability with international research standards. The firm specialises in pharmaceutical market research, KOL mapping, competitive intelligence, market access strategy, HEOR, and brand health tracking — executing bilingual Arabic-English studies across government and private channels.

Key strengths:

2. Kantar Egypt — Global Network, Full-Service

HQ: UK (global) / Egypt office

Kantar maintains an Egypt office within its global network. The firm provides brand tracking, consumer insights, and media measurement at scale. In the healthcare segment, Kantar Health has supported pharma teams with physician studies, patient journey mapping, and syndicated data. Their strength lies in large-scale quantitative programmes and global benchmarking capabilities, though pharma-specific depth in MENA can depend on project staffing.

Key strengths: global brand health and consumer tracking, large quantitative survey infrastructure, syndicated data and media analytics, healthcare division for pharma studies.

3. Ipsos Egypt — Global Network, Full-Service

HQ: France (global) / Egypt office

Ipsos has had a presence in Egypt for over two decades, providing market research across consumer, public affairs, and healthcare sectors. The healthcare division supports pharmaceutical clients with physician attitude and usage studies, patient research, and advertising testing. Ipsos brings strong methodological rigour and large sample capabilities. Egypt-specific pharma depth relies on the availability of specialist healthcare researchers within the local office.

Key strengths: two decades of Egypt presence, healthcare division with pharma methodology, strong quantitative and qualitative methods, public affairs and social research.

4. NielsenIQ — Global Network, Retail & Consumer

HQ: USA (global) / Egypt operations

NielsenIQ provides retail measurement, consumer panels, and shopper analytics in Egypt. Their strength is in FMCG and consumer goods tracking through point-of-sale data and household panels. For pharmaceutical companies focused on OTC and consumer health, Nielsen retail data can be valuable. However, their Egypt coverage is primarily consumer/retail, with limited prescription pharma or healthcare stakeholder research.

Key strengths: retail measurement and shopper panels, FMCG and OTC tracking, point-of-sale data analytics, consumer trend and market sizing.

5. Euromonitor International — Global, Syndicated Intelligence

HQ: UK (global)

Euromonitor provides syndicated market reports and data across industries including consumer health, OTC pharmaceuticals, and consumer goods in Egypt. Their Passport database offers market sizing, competitive landscapes, and trend analysis. For pharmaceutical companies, Euromonitor is valuable for market entry assessment and category sizing but does not offer custom primary research or physician-level fieldwork.

Key strengths: syndicated market data and reports, Egypt consumer health and OTC coverage, market sizing and competitive landscapes, industry trend analysis.

Healthcare vs Consumer: Choosing the Right Research Model

Egypt market research spans two broad domains: healthcare/pharma and consumer/FMCG. Most global networks (Kantar, Ipsos, Nielsen) serve both but through separate divisions with varying depth in pharma-specific work.

For pharmaceutical market research, the key differentiator is access to healthcare professionals. Physician surveys, KOL mapping, payer interviews, and formulary research require specialist recruitment networks and medical terminology expertise. Consumer panels cannot substitute for targeted HCP research.

BioNixus is uniquely positioned as the only firm in this guide offering genuine dual-practice coverage — both healthcare/pharma and consumer research from a US-headquartered operation with regional offices in the UK and Egypt. This means clients working across both domains (e.g., OTC + Rx, or consumer health + specialist pharma) can consolidate with one partner.

For syndicated market data, Euromonitor and NielsenIQ provide valuable sizing and trend information. However, syndicated data should complement, not replace, custom primary research that addresses your specific business questions.

Methodology & Selection Criteria

This guide profiles market research companies with demonstrated presence in Egypt as of 2026. Selection criteria include: (1) active Egypt operations or fieldwork capability, (2) relevance to healthcare, pharmaceutical, or consumer research buyers, (3) established track record with identifiable client engagements. Firms are ordered by Egypt-specific healthcare and pharma capability.

This guide is maintained by the BioNixus research team. BioNixus is profiled in this guide and is transparent about its inclusion. For corrections or updates, contact our team.

Conclusion

Egypt's market research landscape in 2026 offers genuine options across global networks, regional specialists, and local fieldwork firms. For pharmaceutical and healthcare buyers, the critical factor is Egypt-specific depth: EDA regulatory awareness, Arabic-English bilingual execution, physician and KOL recruitment quality, and the ability to translate data into commercial decisions.

BioNixus stands apart as the only dual-practice firm combining healthcare/pharma and consumer research from a US-headquartered operation with regional offices in the UK and Egypt, and a 15-year track record. Whether your need is a focused physician study, a multi-country MENA programme, or a consumer health brand tracker, the right partner will depend on your specific business questions, timeline, and evidence requirements.

For the full BioNixus capability overview, visit the strategic portfolio. For a deeper look at the pharmaceutical industry, see pharmaceutical companies in Egypt. To discuss a specific research need, request a proposal.

Also available: full insights page version and Arabic version.